首页> 外文期刊>Pain. >Complex regional pain syndrome: intradermal injection of phenylephrine evokes pain and hyperalgesia in a subgroup of patients with upregulated alpha(1)-adrenoceptors on dermal nerves
【24h】

Complex regional pain syndrome: intradermal injection of phenylephrine evokes pain and hyperalgesia in a subgroup of patients with upregulated alpha(1)-adrenoceptors on dermal nerves

机译:复杂的区域疼痛综合征:皮内注射苯肾上腺素在皮肤神经上上调α(1)患者的亚组中引起疼痛和痛觉疗程

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to determine whether upregulated cutaneous expression of alpha(1)-adrenoceptors (alpha(1)-AR) is a source of pain in patients with complex regional pain syndrome (CRPS). Immunohistochemistry was used to identify alpha(1)-AR on nerve fibres and other targets in the affected and contralateral skin of 90 patients, and in skin samples from 38 pain-free controls. The distribution of alpha(1)-AR was compared between patients and controls, and among subgroups of patients defined by CRPS duration, limb temperature asymmetry, and diagnostic subtype (CRPS I vs CRPS II). In addition, alpha(1)-AR expression was investigated in relation to pain and pinprick hyperalgesia evoked by intradermal injection of the alpha(1)-AR agonist phenylephrine. Expression of alpha(1)-AR on nerve bundles in the CRPS-affected limb was greater in patients who reported prolonged pain and pinprick hyperalgesia around the phenylephrine injection site than in patients with transient pain after the injection. In addition, alpha(1)-AR expression in nerve bundles was greater in patients with CRPS II than CRPS I, and was greater in acute than more long-standing CRPS. Although less clearly associated with the nociceptive effects of phenylephrine, alpha(1)-AR expression was greater on dermal nerve fibres in the painful than contralateral limb. Together, these findings are consistent with nociceptive involvement of cutaneous alpha(1)-AR in CRPS. This involvement may be greater in acute than chronic CRPS, and in CRPS II than CRPS I.
机译:本研究的目的是确定α(1) - α(1) - α(α(1) - α)的上调皮肤表达是复杂的区域疼痛综合征(CRP)患者的疼痛源。免疫组织化学用于鉴定90例患者的受影响和对侧皮肤的神经纤维和其他靶标的α(1)靶,以及来自38例无疼痛对照的皮肤样品。 α(1)-AR的分布在患者和对照中进行了比较,以及CRPS持续时间,肢体温度不对称和诊断亚型(CRPS I VS CRPS II)定义的患者的亚组之间。此外,研究了α(1)-AR表达,研究了通过皮内注射α(1)激动剂苯妥妥肾上腺素诱捕的疼痛和Pinprick痛觉痛觉痛觉。 α(1)-AR在CRPS患者中的神经束上的表达更大,患者延长疼痛和肾上腺素注射部位周围的疼痛,而不是注射后瞬态疼痛的患者。此外,神经束中的α(1)-AR表达在CRPS II的患者中比CRPS I更大,并且急性急性急剧比较长的CRP更大。虽然与苯妥的伤害效果较小明显相关,但在疼痛的皮神经纤维上比对侧肢体的表达更大。这些发现在一起,与CRP中的皮肤α(1)-AR的伤害性累积一致。这种参与可能比慢性CRP更大,并且在CRPS II中比CRP I I II。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号